Oxford University Press (OUP), Journal of the Pediatric Infectious Diseases Society, 5(8), p. 481-484, 2018
DOI: 10.1093/jpids/piy119
Full text: Unavailable
Abstract In this study, we evaluated posaconazole use among hospitalized children between October 2006 and September 2015 using data from the Pediatric Health Information System. A total of 878 children (in 1949 admissions) received posaconazole, and administration increased 22% per year overall and 27% per year in children aged <13 years for whom the drug was not approved.